RxDoctor Payments Data

Staci Marshall

Nurse Practitioner · Dover, OHNPI 1659675791

Payments from drug & device makers

$1,291in general payments, 2019–2025

Across 97 payments — averaging $13.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$1K
  • Medtronic$99
  • Novo Nordisk$54
  • Vertex$34
  • Tonix Medicines, Inc.$22
  • Si-bone, Inc.$18
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$1,291100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Collegium Pharmaceutical, Inc.86$1,052
Medtronic5$99
Novo Nordisk1$54
Vertex2$34
Tonix Medicines, Inc.1$22
Si-bone, Inc.1$18
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$1,291 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$62,983
Medicare patients
244
Services billed
1,113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate97$46,073
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,001$22,049
Buprenorphine63$20,191
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,160$19,915
NucyntaTapentadol Hcl22$17,814
SavellaMilnacipran Hcl30$14,166
Gabapentin936$11,294
Hysingla ErHydrocodone Bitartrate17$8,498
OxycontinOxycodone Hcl18$6,840
Tramadol Hcl ErTramadol Hcl82$5,166
Morphine Sulfate ErMorphine Sulfate224$4,866
Pregabalin208$4,223
Fentanyl46$3,445
Oxycodone Hcl267$3,432
Tramadol Hcl433$3,013

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta$1,052$63,888119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Dover

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →